Rankings
▼
Calendar
INVA Q4 2021 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$108M
+19.0% YoY
Gross Profit
$108M
100.0% margin
Operating Income
$105M
97.1% margin
Net Income
$10M
9.6% margin
EPS (Diluted)
$0.14
QoQ Revenue Growth
+10.0%
Cash Flow
Operating Cash Flow
$98M
Free Cash Flow
$76M
Stock-Based Comp.
$554,000
Balance Sheet
Total Assets
$926M
Total Liabilities
$400M
Stockholders' Equity
$415M
Cash & Equivalents
$202M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$108M
$90M
+19.0%
Gross Profit
$108M
$90M
+19.3%
Operating Income
$105M
$85M
+23.3%
Net Income
$10M
$54M
-80.8%
Revenue Segments
Royalty
$330M
100%
← FY 2021
All Quarters
Q1 2022 →